世界の癌免疫療法創薬アウトソーシング市場は、2021年に約10億米ドルと評価され、予測期間の2022年から2028年には8.5%を超える健全な成長率で成長すると予測されています。
癌免疫療法に対する医師や患者の認知度が高まっていること、製薬企業やバイオテクノロジー企業が癌治療薬の研究開発に多くの投資を行っていること、世界的に癌の発生率が上昇していることなどから、その人気が拡大しています。また、免疫療法は、癌のリスクを下げ、化学療法後の腫瘍の再発を減少させることが実証されていることから、製薬企業も関心を高めています。例えば、国際癌研究機関（IARC）の推計によると、世界では2018年に1,700万人の癌新規発症者と950万人の癌関連死が発生しています。2040年には、癌の世界的な負担が新たに2750万件に増加すると試算されています。結果的に、M&Aの増加が市場に新たな機会を生み出しています。しかし、創薬CROサービスの品質問題や知的財産権の問題が、2022年から2028年の予測期間において市場の成長を阻害しています。
癌免疫療法創薬アウトソーシングの世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、多数のバイオテクノロジーやライフサイエンス企業、主要なCROが存在することから、市場シェアでは世界一の地域です。さらに、癌免疫療法創薬のアウトソーシングに対する政府の支援もあります。一方、アジア太平洋地域は、費用対効果の高い創薬サービスを提供するCROの増加、先端技術の利用増加、多くの市場参加者が医薬品安全性試験実施基準（GLP）を遵守し、規制ガイドラインに効果的に従っていることから、予測期間の2022年から2028年に大きな成長率を示すと予想されています。
この調査の目的は、近年の様々なセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Drug, 2020-2028 (USD Billion)
1.2.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Service, 2020-2028 (USD Billion)
1.2.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Cancer Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics
3.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing in-house R&D costs
3.1.1.2. Increasing adoption of advanced technologies
3.1.2. Market Challenges
3.1.2.1. Quality issues involved with drug discovery cro services
3.1.2.2. Intellectual property right issues
3.1.3. Market Opportunities
3.1.3.1. Growing mergers and acquisition
3.1.3.2. High prevelance of cancer
Chapter 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Drug
6.1. Market Snapshot
6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Drug, Performance - Potential Analysis
6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Drug 2018-2028 (USD Billion)
6.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Immunomodulators
6.4.3. Cancer Vaccines and Oncolytic Therapies
6.4.4. Others
Chapter 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Service
7.1. Market Snapshot
7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Service, Performance - Potential Analysis
7.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Service 2018-2028 (USD Billion)
7.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
7.4.1. Target Identification and Validation
7.4.2. Lead screening and Characterization
7.4.3. Cell based Assays
Chapter 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Cancer Type
8.1. Market Snapshot
8.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type, Performance - Potential Analysis
8.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Billion)
8.4. Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub Segment Analysis
8.4.1. Lung Cancer
8.4.2. Breast Cancer
8.4.3. Colorectal Cancer
8.4.4. Melanoma
8.4.5. Prostate Cancer
8.4.6. Head and Neck Cancer
8.4.7. Ovarian Cancer
8.4.8. Pancreatic Cancer
Chapter 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Regional Analysis
9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market, Regional Market Snapshot
9.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market
9.2.1. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market
9.2.1.1. Drug estimates & forecasts, 2018-2028
9.2.1.2. Service estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type estimates & forecasts, 2018-2028
9.2.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.3.1. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.4. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.5. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market
9.3.6. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.4.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.4. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.5. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market
9.4.6. Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market
9.5. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
9.5.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market
9.5.2. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market
9.6. Rest of The World Cancer Immunotherapy Drug Discovery Outsourcing Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Explicyte Immuno-Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Aquila Biomedical
10.2.3. Horizon Discovery Group plc
10.2.4. Crown Bioscience Inc.
10.2.5. Promega Corporation.
10.2.6. HD Co. Ltd.
10.2.7. BPS Biosciences Inc.
10.2.8. Gen script Biotech Corporation
10.2.9. Celentyx Ltd.
10.2.10. ImmuneXperts SA
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, report scope
TABLE 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Drug 2018-2028 (USD Billion)
TABLE 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Service 2018-2028 (USD Billion)
TABLE 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by Cancer Type 2018-2028 (USD Billion)
TABLE 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Cancer Immunotherapy Drug Discovery Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 56. List of primary sources, used in the study of global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, research methodology
FIG 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, key trends 2021
FIG 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, growth prospects 2022-2028
FIG 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, porters 5 force model
FIG 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, pest analysis
FIG 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, value chain analysis
FIG 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, regional snapshot 2018 & 2028
FIG 15. North America Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 16. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market 2018 & 2028 (USD Billion)
FIG 19. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, company Market share analysis (2021)
